SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer

Background: Prostate cancer is a major global challenge due to the increasing number of aging population and frequency of diagnosis. During the past decade new treatments have been targeted to the androgen signaling axis either by inhibiting the binding of androgens to androgen receptor (AR) and AR...

Descripción completa

Detalles Bibliográficos
Autores principales: Oksala, Riikka, Karimaa, Mari, Riikonen, Reetta, Räsänen, Kati, Ramela, Meri, Vehmaan-Kreula, Pirjo, Rummakko, Petteri, Wohlfahrt, Gerd, Mustonen, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553147/
http://dx.doi.org/10.1210/js.2019-SUN-LB002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553147/
http://dx.doi.org/10.1210/js.2019-SUN-LB002

Ejemplares similares